BRAF and acral lentiginous melanoma: The mechanisms by which heterogeneous BRAF V600E expression is associated with worse patient survival are under investigation, and we speculate that acral melanomas with heterogeneous BRAF V600E have similar (or more aggressive) biological behavior to those with homogeneous BRAF V600E.